Botanical species · safety record

Hoodia gordonii

The EFSA Compendium of Botanicals holds 6 constituent measurements and 7 adverse-effect records for Hoodia gordonii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hoodia gordonii (Masson) Sweet ex Decne.

6Constituent measurements
7Safety records
8Cited sources
11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Hoodia gordonii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • fluid

Source material stated

  • Aerial parts
  • Herb top
  • Stem
  • Whole plant

What the records describe

Constituents measured

  • Steroidal glycosides4
  • Pregnane1
  • Pregnane derivatives1

Plant parts

  • Aerial part of plants6
  • Unspecified5
  • Stem2
  • stalk2

Preparations

  • Solvent extraction11

Effect types

  • Reproductive3
  • Pulmonary and cardiac2
  • Digestive1
  • Endocrine1

Target tissues

  • Digestive3
  • Glandular1
  • Heart1
  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
PregnaneUnspecifiedSolvent extraction25 Percent—Resolve DOI
Pregnane derivativesAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal glycosidesStem / stalkSolvent extraction≥ 0.78 Percent—Resolve DOI
Steroidal glycosidesStem / stalkSolvent extraction≤ 1.23 Percent—Resolve DOI
Steroidal glycosidesAerial part of plantsSolvent extraction—HPLC with standard detection methodsResolve DOI
Steroidal glycosidesAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecified—Rat (as animal)Acute toxicityResolve DOI
EndocrineGlandularUnspecifiedSolvent extraction—In vitroResolve DOI
Pulmonary and cardiacHeartUnspecified—Human (as organism)Not reportedResolve DOI
Pulmonary and cardiacDigestiveUnspecifiedSolvent extractionHuman (as organism)Not reportedResolve DOI
ReproductiveUterusAerial part of plantsSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveDigestiveAerial part of plantsSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
Reproductive—Aerial part of plantsSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Dent, M. P., Wolterbeek, A. P. M., Russell, P. J., Bradford, R. Safety profile of Hoodia gordonii extract: Mouse prenatal developmental toxicity study . Food and chemical toxicology, 2012, vol. 50, p. S20-S25. DOI
  2. Shukla, Y.J., Khan, I.A., Geoffroy, P., Miesch, M., Atta-ur-Rahman. 14beta-hydroxypregnanes from succulent plants belonging to hoodia gordonii and caralluma genus: Extraction, biological activities, and synthesis. Studies in natural products chemistry, 2013, vol. 40, p. 327-358. DOI
  3. Smith, Carine., Krygsman, Annadie. Hoodia gordonii: To eat, or not to eat. Journal of ethnopharmacology, 2014, vol. 155, no. 2, p. 987-991. DOI
  4. Knight, Tamsin L., Swindells, Chris M., Craddock, Andrew M., Maharaj, Vinesh J., Buchwald-Werner, Sybille., Ismaili, Smail Alaoui., McWilliam, Simon C. Cultivation practices and manufacturing processes to produce Hoodia gordonii extract for weight management products . Food and chemical toxicology, 2012, vol. 50, p. S1-S5. DOI
  5. Komarnytsky, Slavko., Esposito, Debora., Poulev, Alexander., Raskin, Ilya. Pregnane glycosides interfere with steroidogenic enzymes to down-regulate corticosteroid production in human adrenocortical H295R cells . Journal of cellular physiology, 2013, vol. 228, no. 5, p. 1120-1126. DOI
  6. Avula, Bharathi., Wang, Yan-Hong., Pawar, Rahul S., Shukla, Yatin J., Smillie, Troy J., Khan, Ikhlas A. Identification and structural characterization of steroidal glycosides in Hoodia gordonii by ion-trap tandem mass spectrometry and liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry . Rapid communications in mass spectrometry, 2008, vol. 22, no. 16, p. 2587-2596. DOI
  7. Shukla, Yatin J., Pawar, Rahul S., Ding, Yuanqing., Li, Xing-Cong., Ferreira, Daneel., Khan, Ikhas A. Pregnane glycosides from Hoodia gordonii. Phytochemistry, 2009, vol. 70, no. 5, p. 675-683. DOI
  8. Dall'Acqua, Stefano., Innocenti, Gabbriella. Steroidal glycosides from Hoodia gordonii. Steroids, 2007, vol. 72, no. 6-7, p. 559-568. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue